Firefighters should wear a self-contained breathing apparatus and full protective gear. Cool fire-exposed containers with water spray to prevent bursting.

Vapors are heavier than air and may travel to distant and/or low-lying sources of ignition and flashback. Product may produce a floating fire hazard as liquid floats on water. Flame extension is >18 inches, burnback is >3 inches. Use care as spills may be slippery.

Not Established for Mixture. See Section II.

EYE CONTACT: Causes irritation seen as stinging, tearing, redness, and a burning sensation. Prolonged contact may cause conjunctivitis.
SKIN CONTACT: Causes irritation seen as itching and redness. Product may be absorbed through the skin in harmful amounts. Injection under the skin, in muscle, or into the blood stream can cause irritation, inflammation, swelling, fever, and systemic effects, and mild central nervous system depression. Injection of pressurized Hydrocarbons can cause severe, permanent tissue damage. Initial symptoms may be minor. Prolonged or repeated contact, as from clothing wet with material, may cause drying, defatting, and cracking of the skin.
INHALATION: May cause respiratory irritation seen as coughing and sneezing. At low vapor concentrations, no harmful effects are expected. At high vapor concentrations, inhalation may cause central nervous system effects such as headache, dizziness, drowsiness, weakness, unconciousness, possible anesthetic effects from central nervous system depression, and may be fatal.
INGESTION: May cause irritation with possible nausea, vomiting, and diarrhea. May cause central nervous system effects similar to inhalation. Ingestion and subsequent vomiting of this product can lead to aspiration of the product into the lungs which can cause damage and may be fatal.

Remove from the area to fresh air. Seek medical attention if respiratory irritation develops or if breathing becomes difficult.

Rinse the eyes with water. Remove any contact lenses and continue flushing with plenty of water for several minutes. Seek medical attention if irritation develops.

Wash affected areas with large amounts of soap and water for 15 minutes. Remove contaminated clothing and shoes. Seek medical attention if irritation persists. Wash clothing and clean shoes before re-use.

Give 3 to 4 glasses of water, but DO NOT induce vomiting. If vomiting occurs, give fluids again. Get immediate medical attention. Do not give anything by mouth to an unconscious or convulsing person.

Ingestion and subsequent vomiting of this product can lead to aspiration of the product into the lungs which can cause damage and may be fatal. Depending on the amount ingested and retained as well as the toxicity of the product, gastric lavage should be considered. Keep patient's head below hips to prevent pulmonary aspiration. If comatose, a cuffed endotracheal tube will prevent aspiration. In the event of injection in underlying tissue, immediate treatment should include extensive incision, debridement and saline irrigation. Inadequate treatment can result in ischemia and gangrene. Early symptoms may be minimal.

Similar materials were administered orally 5 days/week to male and female rats at 100, 500 or 1000 mg/kg for 13 weeks. An additional group was dosed with 100 mg/kg for 13 weeks followed by a 4-week recovery period. No mortalities or clinical effects were observed. Liver and kidney weights for the 500 and 1000 mg/kg exposure groups were significantly increased. After the 4-week recovery period, there were no differences in organ weights.     3.

Animal data suggest that slight anemia, adaptive liver changes, and kidney toxicity may be caused by repeated overexposure to some similar solvents. The significance of this to humans is unknown.     3.

Hydrocarbon mists derived from highly refined petroleum distillates are reported to have low acute and sub-acute toxicities in animals. Effects from single and short-term repeated exposures to high concentrations well above applicable workplace exposure levels include lung inflammatory reaction, lipoid granuloma formation, and lipoid pneumonia. In acute and sub-acute studies involving exposures to lower concentrations at or near current work place exposure levels produced no significant toxicological effects. In long term studies (up to two years) no carcinogenic effects have been reported in any animal species tested. These petroleum distillates are severely hydrotreated, severely solvent extracted, and/or processed by mild hydrotreatment and extraction. For this reason, they are not classified as cancer hazards.     3.

ETHYL ACETATE
EYE-HMN SDT: 400 ppm                                              4.
IHL-HMN TCLo: 400 ppm                                             4.
ORL-RAT LD₅₀: 5,620 mg/kg                                         3.
IHL-RAT LC₅₀: 16,000 ppm/6h                                      3.
SKN-RBT LD₅₀: >20 mL/kg                                           4.
SKN-RBT LS₅₀: >18,000 mg/kg                                     3.
INH-RAT LC₅₀: 200 gm/m³                                            4.

SODIUM SULFONATE
ORL-RAT LD₅₀: >5,000 mg/kg     3.
SKN-RAT LD₅₀: >2,000 mg/kg     3.

HYDROTREATED LIGHT NAPHTHENIC PETROLEUM DISTILLATE
ORL-RAT LD₅₀: >5 g/kg 3.
SKN-RBT LD₅₀: >3 g/kg 3.
SKN-RBT IRRITATION <0.5/8.0; no appreciable effect 3.
EYE-RBT IRRITATION <15/110; no appreciable effect 3.

PROPANE
IHL-LC₅₀ >40% by volume 4.

N-BUTANE
IHL-RAT LC₅₀: 658 g/m3/4h 3.

Human volunteers exposed repeatedly to gases of similar hydrocarbon mixtures ranging from 250 to 1000 ppm exhibited no cardiac or pulmonary function abnormalities. 3.

SYNTHETIC ISOPARAFFINIC HYDROCARBON (<3% DMSO extractables)
IHL-RAT LC₅₀: >290 ppm 3.
ORL-RAT LD₅₀: >10 g/kg 3.
SKN-RBT LD₅₀: >3 g/kg 3.
SKN SENSITIZER: no 3.
SKN IRRITATION: slight 3.
EYE IRRITATION: slight 3.

This hydrocarbon was administered orally 5 days/week to male and female rats at 100, 500 or 1000 mg/kg for 13 weeks. An additional group was dosed with 100 mg/kg for 13 weeks followed by a 4-week recovery period. No mortalities or clinical effects were observed. Liver and kidney weights for the 500 and 1000 mg/kg exposure groups were significantly increased. After the 4-week recovery period, there were no differences in organ weights. 3.

Strong oxidizing agents such as Chlorine bleach and concentrated Hydrogen Peroxide; Chlorosulfonic Acid, Lithium Aluminum Hydride, 2-Chloromethylfuran, Lithium Tetrahydroaluminate, Oleum, Potassium T-Butoxide, Nitric Acid, Perchloric Acid, Chromium Trioxide, Chlorosulfonic Acid, Silica Gel, Alumina, Nitrates, Amines, strong Acids and Bases.

Oxides of Carbon, Potassium, and, Nitrogen; Aldehydes, Molybdenum, alkylmercaptans, dialkylsulfides, and Hydrogen Sulfides.

Due to the nature of the packaging, a large spill is unlikely. For a small spill, absorb with a damp cloth and rinse area into a sanitary sewer. Use care as spills may be slippery.

Dispose of in accordance with all Federal, state, and local regulations. Typical disposal is to wrap the empty aerosol container in several layers of newspaper and dispose of in the trash. Aerosol recycling programs are available in many areas. Do not puncture or incinerate this container.

Local ventilation is recommended to control exposure from operations that can generate excessive levels of mists or vapors. Local ventilation is preferred, because it prevents dispersion into work areas by controlling it at its source.

Respirators should be selected by and used under the direction of a trained health and safety professional following requirements found in OSHA's respirator standard (29 CFR 1910.134) and ANSI's standard for respiratory protection (Z88.2-1992). For concentrations above the TLV and/or PEL but less than 10 times these limits, a NIOSH approved half-facepiece respirator equipped with appropriate chemical cartridges may be used. For concentrations greater than 10 times the TLV and/or PEL, consult the NIOSH respirator decision logic found in publication No. 87-116 or ANSI Z88.2-1992.

Neoprene or nitrile rubber gloves should be worn. Ensure compliance with OSHA's personal protective equipment (PPE) standard for hand protection, 29 CFR 1910.138.

Safety glasses with side shields if the method of application presents the likelihood of eye contact. Ensure compliance with OSHA's Personal Protective Equipment (PPE) standard for eye and face protection, 29 CFR 1910.133.

Wear protective clothing when handling. Wash clothing and clean shoes before re-use. A safety shower and an eyewash station should be available.

Use with caution around heat, sparks, pilot lights, static electricity, and open flame.

Keep out of reach of children. Read the entire label before using the product. Follow the label directions.